These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 21134407

  • 1. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C.
    J Control Release; 2011 Jun 10; 152(2):208-31. PubMed ID: 21134407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar 10; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 6. Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
    Fazil M, Shadab, Baboota S, Sahni JK, Ali J.
    J Drug Target; 2012 Feb 10; 20(2):97-113. PubMed ID: 22023651
    [Abstract] [Full Text] [Related]

  • 7. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
    Cui Z, Lockman PR, Atwood CS, Hsu CH, Gupte A, Allen DD, Mumper RJ.
    Eur J Pharm Biopharm; 2005 Feb 10; 59(2):263-72. PubMed ID: 15661498
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z, Zhang J, Liu H, Li Y, Zhao Y, Yang E.
    Drug Metab Dispos; 2010 Aug 10; 38(8):1355-61. PubMed ID: 20427691
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.
    Karthivashan G, Ganesan P, Park SY, Kim JS, Choi DK.
    Drug Deliv; 2018 Nov 10; 25(1):307-320. PubMed ID: 29350055
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
    Cummings JL.
    Rev Neurol Dis; 2007 Nov 10; 4(2):57-62. PubMed ID: 17609636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L.
    Future Med Chem; 2010 Nov 10; 2(11):1681-701. PubMed ID: 21428839
    [Abstract] [Full Text] [Related]

  • 16. In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles.
    Härtig W, Kacza J, Paulke BR, Grosche J, Bauer U, Hoffmann A, Elsinghorst PW, Gütschow M.
    Eur J Neurosci; 2010 Jan 10; 31(1):99-109. PubMed ID: 20092557
    [Abstract] [Full Text] [Related]

  • 17. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM, Amiji MM.
    Expert Opin Drug Deliv; 2009 Mar 10; 6(3):211-25. PubMed ID: 19290842
    [Abstract] [Full Text] [Related]

  • 18. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
    Gao X, Wu B, Zhang Q, Chen J, Zhu J, Zhang W, Rong Z, Chen H, Jiang X.
    J Control Release; 2007 Aug 28; 121(3):156-67. PubMed ID: 17628165
    [Abstract] [Full Text] [Related]

  • 19. [Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease].
    Andrieux K, Couvreur P.
    Biol Aujourdhui; 2012 Aug 28; 206(3):185-90. PubMed ID: 23171841
    [Abstract] [Full Text] [Related]

  • 20. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL, Wu XY, Bendayan R.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):686-700. PubMed ID: 22100125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.